Anticoagulation for prevention of stroke

W M Feinberg1

  • 1Comprehensive Stroke Program, The University of Arizona Health Sciences Center, Tucson, USA.

Neurology
|September 23, 1998
PubMed

Insights

Warfarin significantly lowers stroke risk in atrial fibrillation (AF) patients by 70%. Risk stratification helps identify those most benefiting from anticoagulation therapy for stroke prevention.

Area of Science:

  • Cardiology
  • Neurology
  • Pharmacology

Background:

  • Atrial fibrillation (AF) significantly increases stroke risk.
  • Anticoagulation therapy, specifically warfarin, has emerged as a key strategy for stroke prevention in AF patients.
  • Understanding risk stratification is crucial for optimizing treatment decisions.

Purpose of the Study:

  • To summarize the efficacy of warfarin in reducing stroke risk for patients with atrial fibrillation.
  • To highlight the role of risk factors in stratifying stroke risk within the AF population.
  • To discuss the application of anticoagulation in other cardioembolic conditions.

Main Methods:

  • Review of clinical evidence demonstrating warfarin's impact on stroke risk in AF.
  • Analysis of stroke risk based on the presence of additional cardiovascular risk factors.
  • Examination of anticoagulation's benefits in non-AF cardioembolic sources.

Main Results:

  • Anticoagulation with warfarin reduces annual stroke risk in AF patients from 4.5% to 1.5% (a 70% relative risk reduction).
  • Patients with risk factors like prior stroke, hypertension, heart failure, or diabetes have a significantly higher stroke risk (≥8% annually).
  • Low-risk patients (under 75, no risk factors) may benefit from aspirin, while higher-risk patients gain more from anticoagulation.

Conclusions:

  • Warfarin is highly effective in preventing stroke for patients with atrial fibrillation.
  • Risk stratification using factors like age, hypertension, and comorbidities is essential for tailoring anticoagulation therapy.
  • Anticoagulation is also beneficial for stroke prevention in other conditions with cardioembolic potential.

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
Hemorrhagic Stroke ll: Pathophysiology01:29

Hemorrhagic Stroke ll: Pathophysiology

A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...